{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T04:29:46Z","timestamp":1716784186981},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,2,3]]},"DOI":"10.7759\/cureus.34611","type":"journal-article","created":{"date-parts":[[2023,2,4]],"date-time":"2023-02-04T03:26:16Z","timestamp":1675481176000},"source":"Crossref","is-referenced-by-count":1,"title":["Idiopathic Choroidal Neovascularization in Pregnancy: A Case Report"],"prefix":"10.7759","author":[{"given":"Mohammad Daniyal","family":"Monis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanja M","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Israr A","family":"Bhutto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pir S","family":"Mahar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/978-981-15-2213-0_14","article-title":"Idiopathic choroidal neovascularization","author":"Almarek FA","year":"2020","unstructured":"Almarek FA, Alsulaiman SM. Idiopathic choroidal neovascularization. Choroidal Neovascularization. Chhablani, J (ed): Springer, Singapore; 2020. 167-78. 10.1007\/978-981-15-2213-0_14"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/srep31880","article-title":"Idiopathic choroidal neovascularization: Intraocular inflammatory cytokines and the effect of intravitreal ranibizumab treatment","volume":"6","author":"Yin H","year":"2016","unstructured":"Yin H, Fang X, Ma J, et al.. Idiopathic choroidal neovascularization: Intraocular inflammatory cytokines and the effect of intravitreal ranibizumab treatment. Sci Rep. 2016, 6:31880. 10.1038\/srep31880","journal-title":"Sci Rep"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/eye.2017.305","article-title":"Safety of intravitreal injection of ranibizumab in early pregnancy: a series of three cases","volume":"32","author":"Fossum P","year":"2018","unstructured":"Fossum P, Couret C, Briend B, Weber M, Lagarce L. Safety of intravitreal injection of ranibizumab in early pregnancy: a series of three cases. Eye (Lond). 2018, 32:830-2. 10.1038\/eye.2017.305","journal-title":"Eye (Lond)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.survophthal.2012.08.001","article-title":"Pregnancy-associated retinal diseases and their management","volume":"58","author":"Errera MH","year":"2013","unstructured":"Errera MH, Kohly RP, da Cruz L. Pregnancy-associated retinal diseases and their management. Surv Ophthalmol. 2013, 58:127-42. 10.1016\/j.survophthal.2012.08.001","journal-title":"Surv Ophthalmol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s10792-020-01610-2","article-title":"Intravitreal anti-vascular endothelial growth factor medications during pregnancy: current perspective","volume":"41","author":"Naderan M","year":"2021","unstructured":"Naderan M, Sabzevary M, Rezaii K, Banafshehafshan A, Hantoushzadeh S. Intravitreal anti-vascular endothelial growth factor medications during pregnancy: current perspective. Int Ophthalmol. 2021, 41:743-51. 10.1007\/s10792-020-01610-2","journal-title":"Int Ophthalmol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(13)70145-1","article-title":"Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis","volume":"2","author":"Wong WL","year":"2014","unstructured":"Wong WL, Su X, Li X, Cheung CM, Klein R, Cheng CY, Wong TY. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health. 2014, 2:e106-16. 10.1016\/S2214-109X(13)70145-1","journal-title":"Lancet Glob Health"},{"key":"ref7","article-title":"Wet Age-related Macular Degeneration (Wet AMD)","author":"Hobbs SD","year":"2022","unstructured":"Hobbs SD, Pierce K. Wet Age-related Macular Degeneration (Wet AMD). StatPearls,  Treasure Island, FL; 2022."},{"key":"ref8","article-title":"Teratogenic effects of intravitreal injection of bevacizumab in a pregnant rat model","volume":"16","author":"Bamdad S","year":"2017","unstructured":"Bamdad S, Bamdad M, Khanlari M, Daneshbod Y, Khademi B. Teratogenic effects of intravitreal injection of bevacizumab in a pregnant rat model. Iran J Pharm Res. 2017, 16:670-6.","journal-title":"Iran J Pharm Res"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/jpm12091374","article-title":"Association between obstetric complications and intravitreal anti-vascular endothelial growth factor agents or intravitreal corticosteroids","volume":"12","author":"Ben Ghezala I","year":"2022","unstructured":"Ben Ghezala I, Mariet AS, Benzenine E, et al..  Association between obstetric complications and intravitreal anti-vascular endothelial growth factor agents or intravitreal corticosteroids. J Pers Med. 2022, 12:1374. 10.3390\/jpm12091374","journal-title":"J Pers Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/aos.14898","article-title":"Idiopathic multifocal choroiditis and punctate inner choroidopathy: an evaluation in pregnancy","volume":"100","author":"de Groot EL","year":"2022","unstructured":"de Groot EL, van Huet RA, Bloemenkamp KW, de Boer JH, Ossewaarde-van Norel J. Idiopathic multifocal choroiditis and punctate inner choroidopathy: an evaluation in pregnancy. Acta Ophthalmol. 2022, 100:82-8. 10.1111\/aos.14898","journal-title":"Acta Ophthalmol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s10637-016-0361-8","article-title":"Intravitreal vascular endothelial growth factor (VEGF) inhibitor injection in unrecognised early pregnancy","volume":"34","author":"Kianersi F","year":"2016","unstructured":"Kianersi F, Ghanbari H, Naderi Beni Z, Naderi Beni A. Intravitreal vascular endothelial growth factor (VEGF) inhibitor injection in unrecognised early pregnancy. Invest New Drugs. 2016, 34:650-3. 10.1007\/s10637-016-0361-8","journal-title":"Invest New Drugs"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.cn511434-20180731-00261","article-title":"Progress of intravitreal anti-vascular endothelial growth factor during pregnancy","volume":"36","author":"Lao J","year":"2020","unstructured":"Lao J, Mao J, Shen L. Progress of intravitreal anti-vascular endothelial growth factor during pregnancy. Chin J Ocul Fundus Dis. 2020, 36:323-6. 10.3760\/cma.j.cn511434-20180731-00261","journal-title":"Chin J Ocul Fundus Dis"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1038\/eye.2013.311","article-title":"Intravitreal bevacizumab injection in unrecognised early pregnancy","volume":"28","author":"Sullivan L","year":"2014","unstructured":"Sullivan L, Kelly SP, Glenn A, Williams CP, McKibbin M. Intravitreal bevacizumab injection in unrecognised early pregnancy. Eye (Lond). 2014, 28:492-4. 10.1038\/eye.2013.311","journal-title":"Eye (Lond)"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.47102\/annals-acadmedsg.v39n2p143","article-title":"Inadvertent use of bevacizumab to treat choroidal neovascularisation during pregnancy: a case report","volume":"39","author":"Wu Z","year":"2010","unstructured":"Wu Z, Huang J, Sadda S. Inadvertent use of bevacizumab to treat choroidal neovascularisation during pregnancy: a case report. Ann Acad Med Singap. 2010, 39:143-5. 10.47102\/annals-acadmedsg.v39n2p143","journal-title":"Ann Acad Med Singap"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1080\/21556660.2020.1847926","article-title":"Intravitreal vascular endothelial growth factor (VEGF) inhibitor injection in patient during pregnancy","volume":"10","author":"Kianersi F","year":"2021","unstructured":"Kianersi F, Ghanbari H, Naderi Beni Z, Naderi Beni A. Intravitreal vascular endothelial growth factor (VEGF) inhibitor injection in patient during pregnancy. J Drug Assess. 2021, 10:7-9. 10.1080\/21556660.2020.1847926","journal-title":"J Drug Assess"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/134175-idiopathic-choroidal-neovascularization-in-pregnancy-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:50:23Z","timestamp":1707508223000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/134175-idiopathic-choroidal-neovascularization-in-pregnancy-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,3]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.34611","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2,3]]}}}